Treatment of endometriosis, angiogenesis and/or endometrial lesion growth

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11103548
APP PUB NO 20180256670A1
SERIAL NO

15924964

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Synuclein-gamma (SNCG) inhibitors are useful for inhibiting or treating angiogenesis, endometriosis and/or endometrial lesion growth. They also potentiate efficacy of other hormonal agents in treating angiogenesis, endometriosis and/or endometrial lesion growth.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNG PHARMACEUTICALS INC933 JASPER COURT KINGSTON ON K7P 2A4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Singh, Vinay K Kingston, CA 12 90

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 28, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 28, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 28, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00